These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 21527299)

  • 1. The safety evaluation of adjuvants during vaccine development: the AS04 experience.
    Garçon N; Segal L; Tavares F; Van Mechelen M
    Vaccine; 2011 Jun; 29(27):4453-9. PubMed ID: 21527299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of adverse events of potential autoimmune aetiology in a large integrated safety database of AS04 adjuvanted vaccines.
    Verstraeten T; Descamps D; David MP; Zahaf T; Hardt K; Izurieta P; Dubin G; Breuer T
    Vaccine; 2008 Dec; 26(51):6630-8. PubMed ID: 18845199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rebuttal Letter to the Letter to the Editor to "Analysis of adverse events of potential autoimmune aetiology in a large integrated safety database of AS04 adjuvanted vaccines" by T. Verstraeten et al.
    Verstraeten T
    Vaccine; 2009 Apr; 27(19):2530. PubMed ID: 19428857
    [No Abstract]   [Full Text] [Related]  

  • 4. Recent clinical experience with vaccines using MPL- and QS-21-containing adjuvant systems.
    Garçon N; Van Mechelen M
    Expert Rev Vaccines; 2011 Apr; 10(4):471-86. PubMed ID: 21506645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of an AS04-adjuvanted HPV vaccine with the adjuvant system approach.
    Garçon N; Morel S; Didierlaurent A; Descamps D; Wettendorff M; Van Mechelen M
    BioDrugs; 2011 Aug; 25(4):217-26. PubMed ID: 21815697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Meta-analysis of pregnancy outcomes in pooled randomized trials on a prophylactic adjuvanted glycoprotein D subunit herpes simplex virus vaccine.
    Tavares F; Cheuvart B; Heineman T; Arellano F; Dubin G
    Vaccine; 2013 Mar; 31(13):1759-64. PubMed ID: 23313657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. AS04, an aluminum salt- and TLR4 agonist-based adjuvant system, induces a transient localized innate immune response leading to enhanced adaptive immunity.
    Didierlaurent AM; Morel S; Lockman L; Giannini SL; Bisteau M; Carlsen H; Kielland A; Vosters O; Vanderheyde N; Schiavetti F; Larocque D; Van Mechelen M; Garçon N
    J Immunol; 2009 Nov; 183(10):6186-97. PubMed ID: 19864596
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Response to "Analysis of adverse events of potential autoimmune aetiology in a large integrated safety database of AS04 adjuvanted vaccines" by Verstraeten et al.
    Hildesheim A; Schiffman M; Solomon D; Wacholder S; Rodriguez AC; Herrero R
    Vaccine; 2009 Apr; 27(19):2529. PubMed ID: 19186195
    [No Abstract]   [Full Text] [Related]  

  • 9. AS04-adjuvanted human papillomavirus-16/18 vaccination: recent advances in cervical cancer prevention.
    Schwarz TF
    Expert Rev Vaccines; 2008 Dec; 7(10):1465-73. PubMed ID: 19053203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of new onset autoimmune disease in 9- to 25-year-old women exposed to human papillomavirus-16/18 AS04-adjuvanted vaccine in the United Kingdom.
    Willame C; Rosillon D; Zima J; Angelo MG; Stuurman AL; Vroling H; Boggon R; Bunge EM; Pladevall-Vila M; Baril L
    Hum Vaccin Immunother; 2016 Nov; 12(11):2862-2871. PubMed ID: 27428517
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of AS04 in human papillomavirus vaccine: mode of action and clinical profile.
    Garçon N; Wettendorff M; Van Mechelen M
    Expert Opin Biol Ther; 2011 May; 11(5):667-77. PubMed ID: 21457083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of adjuvants on the safety and immunogenicity of an avian influenza H5N1 vaccine in adults.
    Bernstein DI; Edwards KM; Dekker CL; Belshe R; Talbot HK; Graham IL; Noah DL; He F; Hill H
    J Infect Dis; 2008 Mar; 197(5):667-75. PubMed ID: 18260764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A review of the current status of oil adjuvants in foot--and--mouth disease vaccines.
    McKercher PD; Graves JH
    Dev Biol Stand; 1976; 35():107-12. PubMed ID: 198275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A rapid immune response to 2009 influenza A(H1N1) vaccines in adults: a randomized, double-blind, controlled trial.
    Wu J; Li W; Wang HQ; Chen JT; Lv M; Zhou JC; Liang XF; Fang HH; Liu Y; Liu LY; Wang X; Zhang WL; Zhang XM; Song LF; Qiu YZ; Li CG; Wang JZ; Wang Y; Yin WD
    J Infect Dis; 2010 Sep; 202(5):675-80. PubMed ID: 20632888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Priming with AS03 A-adjuvanted H5N1 influenza vaccine improves the kinetics, magnitude and durability of the immune response after a heterologous booster vaccination: an open non-randomised extension of a double-blind randomised primary study.
    Leroux-Roels I; Roman F; Forgus S; Maes C; De Boever F; Dramé M; Gillard P; van der Most R; Van Mechelen M; Hanon E; Leroux-Roels G
    Vaccine; 2010 Jan; 28(3):849-57. PubMed ID: 19835828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical update of the AS04-adjuvanted human papillomavirus-16/18 cervical cancer vaccine, Cervarix.
    Schwarz TF
    Adv Ther; 2009 Nov; 26(11):983-98. PubMed ID: 20024678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preclinical development of AS04.
    Garçon N
    Methods Mol Biol; 2010; 626():15-27. PubMed ID: 20099118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibody and T-cell responses to a virosomal adjuvanted H9N2 avian influenza vaccine: impact of distinct additional adjuvants.
    Radosević K; Rodriguez A; Mintardjo R; Tax D; Bengtsson KL; Thompson C; Zambon M; Weverling GJ; Uytdehaag F; Goudsmit J
    Vaccine; 2008 Jul; 26(29-30):3640-6. PubMed ID: 18514980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunogenicity, safety, and cross-reactivity of an inactivated, adjuvanted, prototype pandemic influenza (H5N1) vaccine: a phase II, double-blind, randomized trial.
    Wu J; Fang HH; Chen JT; Zhou JC; Feng ZJ; Li CG; Qiu YZ; Liu Y; Lu M; Liu LY; Dong SS; Gao Q; Zhang XM; Wang N; Yin WD; Dong XP
    Clin Infect Dis; 2009 Apr; 48(8):1087-95. PubMed ID: 19281330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the effects of five adjuvants on the antibody response to influenza virus antigen in guinea pigs.
    Robuccio JA; Griffith JW; Chroscinski EA; Cross PJ; Light TE; Lang CM
    Lab Anim Sci; 1995 Aug; 45(4):420-6. PubMed ID: 7474883
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.